You just read:

Glenmark Pharmaceuticals Announces Oral Presentation of New Data on GBR 830, an Investigational, Anti-OX40 Monoclonal Antibody, at the International Investigative Dermatology Meeting

News provided by

Glenmark Pharmaceuticals

May 17, 2018, 02:00 ET